Synthesis of a DOTA- C -glyco bifunctional chelating agent and preliminary in vitro and in vivo study of [68 Ga]Ga-DOTA- C -glyco-RGD - Université de Lorraine Accéder directement au contenu
Article Dans Une Revue RSC Advances Année : 2021

Synthesis of a DOTA- C -glyco bifunctional chelating agent and preliminary in vitro and in vivo study of [68 Ga]Ga-DOTA- C -glyco-RGD

Floriane Mangin
Julien Pierson
  • Fonction : Auteur
  • PersonId : 1354019
Cédric Boura

Résumé

The design of bifunctional chelating agents (BFCA) allowing straightforward radiometal labelling of biomolecules is a current challenge. We report herein the development of a bifunctional chelating agent based on a DOTA chelator linked to a C-glycosyl compound, taking advantage of the robustness and hydrophilicity of this type of carbohydrate derivative. This new BFCA was coupled with success by CuAAC with c(RGDfK) for αvβ3 integrin targeting. As attested by in vitro evaluation, the conjugate DOTA-C-glyco-c(RGDfC) demonstrated high affinity for αvβ3 integrins (IC50 of 42 nM). [68Ga]Ga-DOTA-C-glyco-c(RGDfK) was radiosynthesized straightforwardly and showed high hydrophilic property (log D7.4 = −3.71) and in vitro stability (>120 min). Preliminary in vivo PET study of U87MG engrafted mice gave evidence of an interesting tumor-to-non-target area ratio. All these data indicate that [68Ga]Ga-DOTA-C-glyco-c(RGDfK) allows monitoring of αvβ3 expression and could thus be used for cancer diagnosis. The DOTA-C-glycoside BFCA reported here could also be used with various ligands and chelating other (radio)metals opening a broad scope of applications in imaging modalities and therapy.

Domaines

Chimie
Fichier principal
Vignette du fichier
revised manuscript-HAL.pdf (975.42 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-03155777 , version 1 (29-09-2021)

Identifiants

Citer

Floriane Mangin, Charlotte Collet, Valérie Jouan-Hureaux, Fatiha Maskali, Emilie Roeder, et al.. Synthesis of a DOTA- C -glyco bifunctional chelating agent and preliminary in vitro and in vivo study of [68 Ga]Ga-DOTA- C -glyco-RGD. RSC Advances, 2021, 11 (13), pp.7672-7681. ⟨10.1039/D0RA09274F⟩. ⟨hal-03155777⟩
138 Consultations
90 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More